论文部分内容阅读
目的：观察参芪注射液对食管癌放疗的增效减毒作用。方法：对102例食管鳞癌病人采用参芪注射合并放疗与单纯放疗前瞻性随机分组研究。结果:综合组的1年生存率及近期显效率分别为67.3％、87.2％，显著高于单纯放疗组（P＜0.01），显示参芪注射液合并放疗提高食管癌放疗疗效，并能减轻食管癌放疗致血象下降的毒性反应。结论:参芪注射液有助于提高食管癌放疗的疗效。
Objective: To observe the synergistic and attenuating effects of Shenqi injection on radiotherapy of esophageal cancer. METHODS: A prospective randomized subgroup study of 102 patients with esophageal squamous cell carcinoma was performed with Shenqi injection combined with radiotherapy and radiotherapy alone. Results: The 1-year survival rate and recent effective rate of the comprehensive group were 67.3% and 87.2%, respectively, which was significantly higher than that of the radiotherapy alone group (P<0.01). It was shown that Shenqi injection combined with radiotherapy can improve the curative effect of esophageal cancer radiotherapy and reduce the esophagus. Carcinoma radiation-induced cytotoxicity. Conclusion: Shenqi injection can improve the curative effect of esophageal cancer radiotherapy.